Amarantus will have more recognition walking into

Amarantus will have more recognition walking into this conference than any others in the past.

The person that is the Co-Founding Chairman and President, Abraham Fisher, PhD is on the SAB of Anavax.

Other direct relationships we have at the conference other than the Chairman & President is Colin Masters, Paul Aisen, MD, and Jeffrey Cummings, MD.

One can argue so what. I would argue that is short sighted. Would these people who are literally the Top in the World and on the cutting edge of Everything pertaining to ALZ would allow Amarantus to present sub par data with their recommendations of LymPro? And yes, they had to put their reputation on the line to agree to use LymPro seeing they are the SAB of Anavex.

http://www2.kenes.com/adpd/info/Pages/WelcometoADPD.aspx
Abraham Fisher, PhD - Co-Founding Chairman and President
Colin L. Masters

http://www2.kenes.com/adpd/exh/Pages/TheIndus...sions.aspx
Jeffrey Cummings, MD

http://www.anavex.com/about-us/leadership/
Scientific Advisory Board
Abraham Fisher, PhD
Jeffrey Cummings, MD
Paul Aisen, MD

http://pranabio.com/about/#.VQhEdWK9KSM
Jeffrey Cummings, MD
Colin L. Masters

How will it translate to the pps? I have no idea. We may even drop. But, the long term overview is that Amarantus is building relationships that will most certainly pay off in the long run. These relationships are WorldClass.

Cheers